U.S. markets closed

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.6700+0.2800 (+20.14%)
At close: 4:00PM EDT

1.6600 -0.01 (-0.60%)
After hours: 7:59PM EDT

Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 5/12/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.79
52-Week Change 3-80.34%
S&P500 52-Week Change 339.22%
52 Week High 39.7800
52 Week Low 30.9100
50-Day Moving Average 31.7615
200-Day Moving Average 31.7794

Share Statistics

Avg Vol (3 month) 35.95M
Avg Vol (10 day) 32.64M
Shares Outstanding 5125.03M
Implied Shares Outstanding 6N/A
Float 123.45M
% Held by Insiders 10.42%
% Held by Institutions 137.11%
Shares Short (Apr 29, 2021) 413.74M
Short Ratio (Apr 29, 2021) 44.68
Short % of Float (Apr 29, 2021) 411.05%
Short % of Shares Outstanding (Apr 29, 2021) 410.99%
Shares Short (prior month Mar 30, 2021) 410.84M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-3,119.20%

Management Effectiveness

Return on Assets (ttm)-101.37%
Return on Equity (ttm)-432.68%

Income Statement

Revenue (ttm)3.94M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)-74.40%
Gross Profit (ttm)-94.33M
EBITDA -121.69M
Net Income Avi to Common (ttm)-111.27M
Diluted EPS (ttm)-1.4240
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)85.43M
Total Cash Per Share (mrq)0.68
Total Debt (mrq)26.84M
Total Debt/Equity (mrq)59.27
Current Ratio (mrq)2.89
Book Value Per Share (mrq)0.46

Cash Flow Statement

Operating Cash Flow (ttm)-99.69M
Levered Free Cash Flow (ttm)-67.09M